Premature immunosenescence impairs immune surveillance allowing the endometriotic stem cell to migrate: The cytokine profile as a common denominator

Journal of Endometriosis

Volumn 2, Issue 1, 2010, Pages 7-18

  Vassiliadis, Simon ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Cytokines; Endometriosis; Immune surveillance; Premature immune senescence; Stem cell

Indexed keywords

APOPTOSIS INHIBITOR; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

BONE MARROW CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; ENDOMETRIOSIS; ENDOMETRIUM CELL; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; IMMUNOSURVEILLANCE; IN VITRO STUDY; STEM CELL; STOCHASTIC MODEL;

EID: 78549234070     PISSN: 20359969     EISSN: 2036282X     Source Type: Journal    
DOI: 10.1177/228402651000200103     Document Type: Conference Paper

References (115)

1. Iwanoff NS. Druesiges zysthaltiges Uterusfibromyoma kompliziert druch Sarkom und Karzinom (adenofibromyoma cysticum sarcomatodes carcinomatosum). Mschr Geburtsh Gynecol 1898; 7: 295-300.
2. Halban J. Hysteroadenosis matastatica. Die lymphofene genese der sogenannte adenofibromatosis heterotopica. Wien Klin Wschr 1925; 37: 1205-10.
3. Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissues into the peritoneal cavity. Am J Obstet Gynecol 1927; 14: 422-69.
4. Taylor HS. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 2004; 292: 81-5.
5. Gargett CE. Uterine stem cells: What is the evidence? Hum Reprod Update 2007; 13: 87-101.
6. Meng X, Ichim TE, Zhong J, et al. Endometrial regenerative cells: A novel stem cell population. J Translat Med 2007; 5: 57-66.
7. Schwab KE, Gargett CE. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum Reprod 2007; 22: 2903-11.
8. Schwab KE, Hutchinson P, Gargett CE. Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells. Hum Reprod 2008; 23: 934-43.
9. Simpson JL, Elias S, Malinak LR, Buttram VC. Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol 1980; 137: 327-31.
10. Panidis DK, Matalliotakis IM. Subfertility associated with minimal to mild endometriosis. Main Mechanisms. J Reprod Med 1998; 42: 1034-42.
11. D'Hooghe TM, Debrock S, Hill JA, Meuleman C. Endometriosis and subfertility: is the relationship resolved? Semin Reprod 2003; M21: 243-53.
12. Gianetto-Berrutti A, Feyles V. Endometriosis related to infertility. Minerva Gynecol 2003; 22: 407-16.
13. Summaria V, Speca S, Mirk P. Ovarian factor infertility. Rays 1998; 23: 709-26.
14. Halis G, Arici A. Endometriosis and inflammation in infertility. Ann NY Acad Sci 2004; 1034: 300-15.
15. Senturk L, Arici A. Immunology of endometriosis. J Reprod Immunol 1998; 43: 67-83.
16. Vassiliadis S, Relakis K, Papageorgiou A, Athanassakis I. Endometriosis and infertility: a multi-cytokine imbalance versus ovulation, fertilization and early embryo development. Clin Dev Immunol 2005; 12: 125-9.
17. Furuya K, Murakami M, Makimura N, et al. Immunological and endocrinological studies on lymphocyte subpopulation and medical treatment for infertility in patients with endometriosis. Molec Cell Endocrinol 2003; 202: 195-9.
18. Vinatier D, Dufour P, Oosterlynck D. Immunological aspects of endometriosis. Hum Reprod Update 1996; 2: 371-84.
19. Crisp TM, Clegg ED, Cooper RL, et al. Environmental endocrine disruption: An effects assessment and analysis. Environ Health Perspect 1998; 106: (Suppl 1): 11-56.
20. Stefansson H, Geirsson RT, Steinthorsdottir V, et al. Genetic factors contribute to the risk of developing endometriosis. Hum Reprod 2002; 17: 555-9.
21. Meyer W. Transthoracic laparotomy. Ann Surg 1919; 70: 172-8.
22. Levander G, Normann P. The pathogenesis of endometriosis; an experimental study. Acta Obstet Gynecol Scand 1955; 34: 366-98.
23. Batt RE, Smith RA. Embryologic theory of histogenesis of endometriosis in peritoneal pockets. Obstet Gynecol Clin North Am 1989; 16: 15-28.
24. Matalliotakis IM, Cakmak H, Koumantakis EE, Margariti A, Neonaki M, Goumenou AG. Arguments for a left lateral predisposition of endometrioma. Fertil Steril 2009; 91: 975-8.
25. Ulcová-Gallová Z, Bouse V, Svábek L, Turek J, Rokyta Z. Endometriosis in reproductive immunology. Am J Reprod Immunol 2002; 47: 269-74.
26. Iborra A, Palacio JR, Ulcová-Gallová Z, Martinez P. Autoimmune response in women with endometriosis. Am J Reprod Immunol 2000; 44: 236-41.
27. Kyama CM, Debrock S, Mwenda JM, D'Hooghe TM. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol 2003; 1: 123-31.
28. Matalliotakis IM, Vassiliadis S, Goumenou AG, Fragouli Y, Athanassakis I. Suggested markers for the diagnosis of Endometriosis. Curr Wom Health Rev 2008; 4: 25-8.
29. Wu M-Y, Ho H-N. The role of cytokines in endometriosis. Am J Reprod Immunol 2003; 49: 285-96.
30. Fukaya T, Sugawara J, Yoshida H, Yajima A. The role of macrophage colony stimulating factor in the peritoneal fluid in infertile patients with endometriosis. J Exp Med 1994; 172: 221-6.
31. Luk J, Seval Y, Kayisli UA, Ulukus M, Ulukus CE, Arici A. Regulation of interleukin-8 expression in human endometrial endothelial cells: a potential mechanism for the pathogenesis of endometriosis. J Clin Endocrinol Metab 2005; 90: 1805-11.
32. Bersinger NA, von Roten S, Wunder DM, Raio L, Dreher E, Mueller MD. PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis. Am J Obstet Gynecol 2006; 195: 103-8.
33. Wieser F, Dogan S, Klingel K, Diedrich K, Taylor RN, Hornung D. Expression and regulation of CCR1 in peritoneal macrophages from women with and without endometriosis. Fertil Steril 2005; 83: 1878-81.
34. Antinolo G, Fernandez RM, Noval JA, Molini JL, Borrego S. Analysis of the involvement of CCR5-Delta32 and CCR2-V64I variants in the development of endometriosis. Mol Hum Reprod 2004; 10: 155-7.
35. Matalliotakis IM, Goumenou AG, Koumantakis GE, et al. Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol 2003; 3: 81-9.
36. Matalliotakis IM, Goumenou AG, Koumantakis GE, et al. Expression of serum human leukocyte antigen (HLA) and growth factor levels in a Greek case of familial endometriosis. J Soc Gynecol Invest 2003; 10: 118-21.
37. Matalliotakis IM, Vassiliadis S, Goumenou AG, et al. Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment. J Reprod Immunol 2001; 51: 9-19.
38. Arici A, Matalliotakis I, Goumenou A, et al. Increased levels of interleukin-15 in the peritoneal fluid of women with endometriosis: inverse correlation with stage and depth of invasion. Hum Reprod 2003; 18: 429-32.
39. Arici A, Matalliotakis I, Goumenou A, Koumantakis G, Vassiliadis S, Mahutte NG. Altered expression of interleukin-18 in the peritoneal fluid of women with endometriosis. Fertil Steril 2003; 80: 889-94.
40. Matalliotakis I, Athanassakis I, Neonaki M, Goumenou A, Vassiliadis S, Koumantakis E. The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot. Mediators Inflamm 2001; 10: 75-80.
41. Robert C, Kupper TS. Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 1999; 341: 1817-28.
42. Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunol 2007; 121: 1-14.
43. Malaguarnera L, Ferlito L, Imbesi RM, et al. Immunosenescence: a review. Arch Gerontol Geriatr 2001; 32: 1-14.
44. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal bone marrow cells. Radiation Res 1961; 14: 213-22.
45. Maximow AA. Relation of blood cells to connective tissues and endothelium. Physiol Res 1924; 4: 533-63.
46. Till JE, McCulloch EA, Siminovitch L. A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. Proc Natl Acad Sci USA 1964; 51: 29-36.
47. McCulloch EA. Stem Cells in Normal and Leukemic Hemopoiesis. Blood 1983; 62: 1-13.
48. Ogawa M, Porter PN, Nakahata T. Renewal and commitment to differentiation of hemopoietic Stem cells (An interpretive review). Blood 1983; 61: 823-9.
49. Smith LJ, Curtis JE, Messner HA, Senn JS, Furthmayr H, McCulloch EA. Lineage infidelity in acute leukaemia. Blood 1983; 61: 1138-45.
50. Palumbo A, Minowada J, Erikson J, Croce CM, Rovera G. Lineage infidelity of a human myelogenous leukemia cell line. Blood 1984; 64: 1059-63.
51. Greaves MF, Chan LC, Furley AJ, Watt SM, Molgaard HV. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 1986; 67: 1-11.
52. Trenton JJ. Influence of hematopoietic organ stroma on stem cell differentiation. In: Gordon AS (ed). Regulatory Hematopoiesis. New York: Appleton-Century-Crofts, 1970.
53. Vassiliadis S. Growth of acute myeloid leukemia cells on bone marrow feeder layers is supported by cellular interactions rather than growth factor production. Haematologia 1994; 26: 29-37.
54. Schmitt-Gräff A, Desmoulière A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Archiv 1994; 425: 3-24.
55. Vassiliadis S, Kalmanti M, Athanassakis I. Plasticity: Advantages over cloning and gene therapy. Haematologia 2002; 32: 337-9.
56. Okada TS. "Transdifferentiation" of cells from chick embryonic eye tissues in cell culture. Devel Growth Differ 1975; 17: 289-90 [Résumés au Congrès Franco-Japonais (1975)].
57. Iscove NN, Senn JS, Till JE, McCulloch E.A. Colony formation by normal and leukemic human marrow cells in culture: Effect of conditioned medium from human leukocytes. Blood 1971; 37: 1-5.
58. Vassiliadis S. Guided myeloid leukemia cell differentiation by blocking a specific cell cycle stage. Int J Hematol 1996; 63: 235-9.
59. Vassiliadis S, Evangeliou A, Basta E, Dionyssopoulou E, Dimitriou H, Stiakaki E, Kalmanti M, Athanassakis I. The role of L-Carnitine on a restricted number of myeloid leukemia progenitor cells: Generation of atypical cell types. Haematologia 2002; 32: 341-53.
60. Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC. Dendritic cells as the terminal stage of monocytic differentiation. J Immunol 1998; 160: 4587-95.
61. Lee CK, Kim JK, Kim Y, et al. Generation of macrophages from early T progentitors in vitro. J Immunol 2001; 166: 5964-9.
62. Manabe N, Kawaguchi H, Chikuda H, et al. Connection between B lymphocyte and osteoclast differentiation pathways. J Immunol 2001; 167: 2625-31.
63. Horowitz MC. Cytokines and estrogen in bone: anti-osteoporotic effects. Science 1993; 260: 626-7.
64. Dickson DW, Mattiace LA, Kure K, Hutchins K, Lyman WD, Brosnan CF. Biology of disease: microglia inhuman disease with emphasis on acquired deficiency syndromes. Lab Invest 1991; 64: 135-41.
65. Du H, Taylor HS. Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells 2007; 25: 2082-6.
66. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril 2001; 75: 1-10.
67. Gebel HM, Braun DP, Tambur A, Frame D, Rana N, Dmowski WP. Spontaneous apoptosis of tissue is impaired in women with endometriosis. Fertil Steril 1998; 69: 1042-4.
68. Asher AL, Mule JJ, Kasid A, et al. Murine tumor cells transduced with the gene for tumor necrosis factor- alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors. J Immunol 1991; 146: 3227-34.
69. Perez D, White E. TNF-α signals apoptosis through a bid-dependent conformational change in Bax that is inhibited by E1B 19K. Molec Cell 2000; 6: 53-63.
70. Tarkowski R, Kotarski J, Polak G, Wojcierowski J. Expression of the survivin gene in the scar endometriosis and in normal human endometrium. Ginekol Pol 2001; 72: 1539-42.
71. Ho H-N, Wu M-Y, Chao K-H, et al. Decrease in interferon gamma production and impairment of T-lymphocyte proliferation in peritoneal fluid of women with endometriosis. Am J Obstet Gynecol 1996; 175: 1236-41.
72. Rana N, Braun DP, House R, Gebel H, Rotman C, Dmowski WP. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertil Steril 1996; 65: 925-30.
73. Koga K, Osuga Y, Yoshino O, et al. Elevated interleukin-16 levels in the peritoneal fluid of women with endometriosis may be a mechanism for inflammatory reactions associated with endometriosis. Fertil Steril 2005; 83: 878-82.
74. Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Devel 1998; 102: 199-209.
75. Abbate A, Scarpa S, Santini D, et al. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat. Int J Cardiol 2006; 111: 371-6.
76. Kooy AJ, Tank B, Vuzevski VD, van Joost T, Prens EP. Expression of interferon-gamma receptors and interferon-gamma-induced up-regulation of intercellular adhesion molecule-1 in basal cell carcinoma; decreased expression of IFN-γR and shedding of ICAM-1 as a means to escape immune surveillance. J Pathol 1998; 184: 169-76.
77. Yumoto E, Higashi T, Nouso K, et al. Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J Gastroenterol Hepatol 2002; 17: 285-94.
78. Nishida M, Nasu K, Ueda T, Fukuda J, Takai N, Miyakawa I. Endometriotic cells are resistant to interferon-gamma-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis. Mol Hum Reprod 2005; 11: 29-34.
79. Klein NA, Pérgola GM, Tekmal RR, Montoya IA, Dey TD, Schenken RS. Cytokine regulation of cellular proliferation in endometriosis. Ann NY Acad Sci 1994; 734: 322-32.
80. Le Gouvello S, Bastuji-Garin S, Aloulou N, et al. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 2008; 57: 772-9.
81. Ginaldi L, Loreto MF, Corsi MP, Modesti M, De Martinis M. Immunosenescence and infectious diseases. Microbes Infect 2001; 3: 851-7.
82. Boussiotis VA, Tsai EY, Yunis EJ, et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000; 105: 1317-25.
83. Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nature Rev Immunol 2004; 4: 211-22.
84. Antsiferova YS, Sotnikova NY, Posiseeva LV, Shor AL. Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis. Fertil Steril 2005; 84: 1705-11.
85. Szyllo K, Tchorzewski H, Banasik M, Glowacka E, Lewkowicz P, Kamer-Bartosinska A. The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis. Mediators Inflamm 2003; 12: 131-8.
86. Hsu CC, Yang BC, Wu MH, Huang KE. Enhanced interleukin-4 expression in patients with endometriosis. Fertil Steril 1997; 67: 1059-64.
87. Franceschi C, Valensin S, Fagnoni F, Barbi C, Bonafè M. Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load. Exper Gerontol 1999; 34: 911-21.
88. Nakashima J, Tachibana M, Horiguchi Y, et al. Serum interleukin 6 as a prognostic factor in patients with prostate cancer. Clin Cancer Res 2000; 6: 2702-6.
89. Thorbecke GJ, Ponzio MN. Reverse immune surveillance: an adaptive mechanism used by tumor cells to facilitate their survival and growth. Semin Cancer Biol 2000; 10: 327-30.
90. Gangemi S, Basile G, Monti D, et al. Age-related modifications in circulating IL-15 levels in humans. Mediators Inflamm 2005; 2005: 245-7.
91. Kirman I, Vainer B, Nielsen OH. Interleukin-15 and its role in chronic inflammatory diseases. Inflamm Res 1998; 47: 285-9.
92. Gangemi S, Basile G, Merendino RA, et al. Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: another paradox of longevity? Exper Gerontol 2003; 38: 669-72.
93. Cho D, Song H, Kim YM, et al. Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates. Cancer Res 2000; 60: 2703-9.
94. Stout RD, Suttles J. Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol Rev 2005; 205: 60-71.
95. Dace DS, Apte RS. Effect of senescence on macrophage polarization and angiogenesis. Rejuvenation Res 2008; 11: 177-85.
96. Ohm JE, Carbone DP. VEGF as a mediator of tumor-associated immunodeficiency. Immunol Res 2001; 23: 263-72.
97. Vicari AP, Caux C, Trinchieri G. Tumour escape from immune surveillance through dendritic cell inactivation. Semin Cancer Biol 2002; 12: 33-42.
98. Gorgoulis VG, Pratsinis H, Zacharatos P, et al. p53-dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions. Lab Invest 2005; 85: 502-11.
99. Viganó P, Pardi R, Magri B, Busacca M, Di Blasio AM, Vignali M. Expression of ICAM-1 on cultured human endometrial stromal cells and its role in the inter38action with natural killers. Am J Reprod Immunol 1994; 32: 139-45.
100. Somigliana E, Viganò P, Gaffuri B, Guarneri D, Busacca M, Vignali M. Human endometrial stromal cells as a source of soluble intercellular adesion molecule (ICAM)-1 molecules. Hum Reprod 1996; 11: 1190-4.
101. De Placido G, Alviggi C, Di Palma G, et al. Serum concentrations of soluble human leukocyte class I antigens and of the soluble intercellular adhesion molecule-1 in endometriosis: relationship with stage and non-pigmented peritoneal lesions. Hum Reprod 1998; 13: 3206-10.
102. Wu M-H, Yang B-C, Lee Y-C, Wu P-L, Hsu C-C. The differential expression of intercellular adhesion molecule-1 (ICAM-1) and regulation by interferon-gamma during the pathogenesis of endometriosis. Am J Reprod Immunol 2004; 51: 373-80.
103. Anastassiou G, Schilling H, Stang A, Djakovic S, Heiligenhaus A, Bornfeld N. Expression of the cell adhesion molecules ICAM-1, VCAM-1 and NCAM in uveal melanoma: A clinicopathological study. Oncology 2000; 58: 83-8.
104. Shirai A, Furukawa M, Yoshizaki T. Expression of intercellular adhesion molecule (ICAM)-1 in Adenoid cystic carcinoma of the head and neck. Laryngoscope 2003; 113: 1955-60.
105. Calhaz-Jorge C, Costa A, Santos, MC, Palma-Carlos M.L. Soluble intercellular adhesion molecule 1 in the peritoneal fluid of patients with endometriosis correlates with the extension of peritoneal implants. Eur J Obstet Gynecol Reprod Biol 2003; 106: 170-4.
106. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 2002; 169: 4697-701.
107. Sebastián C, Espia M, Serra M, Celada A, Lloberas J. MacrophAging: A cellular and molecular review. Immunobiol 2005; 210: 121-6.
108. Huang B, Zhao J, Li H, et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005; 65: 5009-14.
109. Young SL, Lyddon TD, Jorgenson RL, Misfeldt ML. Expression of Toll-like receptors in human endometrial epithelial cells and cell lines. Am J Reprod Immunol 2004; 52: 67-73.
110. Mahutte NG, Matalliotakis IM, Goumenou AG, Koumantakis GE, Vassiliadis S, Arici A. Elevations in peritoneal fluid macrophage migration inhibitory factor are independent of the depth of invasion or stage of endometriosis. Fertil Steril 2004; 82: 97-101.
111. Roger T, David J, Glauser MP, Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001; 414: 920-4.
112. Anjos-Afonso F, Bonnet D. Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood 2007; 109: 1298-306.
113. Minguell JJ, Erices A, Conget P. Mesenchymal Stem Cells. Exp Biol Med 2001; 226: 507-20.
114. Short B, Brouard N, Occhiodoro-Scott T, Ramakrishnan A, Simmons PJ. Mesenchymal stem cells. Arch Med Res 2003; 34: 565-71.
115. Caplan AI. Mesenchymal Stem cells. In: Lanza R, Blau H, Melton D, et al (eds). Handbook of Stem Cells, Vol. 2: Adult and fetal stem cells. Elsevier Academic Press 2004, pp. 299-308.